Login / Signup

Photoactivatable Liposomes for Blue to Deep Red Light-Activated Surface Drug Release: Application to Controlled Delivery of the Antitumoral Drug Melphalan.

Anaïs BrionJuliane ChaudMaxime KlimezakFrédéric BolzeLaura OhlmannJérémie LéonardStefan ChassaingBenoît FrischAntoine KichlerBéatrice HeurtaultAlexandre Specht
Published in: Bioconjugate chemistry (2023)
Liposome-based nanoparticles able to release, via a photolytic reaction, a payload anchored at the surface of the phospholipid bilayer were prepared. The liposome formulation strategy uses an original drug-conjugated blue light-sensitive photoactivatable coumarinyl linker. This is based on an efficient blue light-sensitive photolabile protecting group modified by a lipid anchor, which enables its incorporation into liposomes, leading to blue to green light-sensitive nanoparticles. In addition, the formulated liposomes were doped with triplet-triplet annihilation upconverting organic chromophores (red to blue light) in order to prepare red light sensitive liposomes able to release a payload, by upconversion-assisted photolysis. Those light-activatable liposomes were used to demonstrate that direct blue or green light photolysis or red light TTA-UC-assisted drug photolysis can effectively photorelease a drug payload (Melphalan) and kill tumor cells in vitro after photoactivation.
Keyphrases
  • drug release
  • drug delivery
  • high dose
  • photodynamic therapy
  • emergency department
  • light emitting
  • quantum dots
  • adverse drug